Detroit voters approved a ballot initiative to widely decriminalize psychedelics, making it the latest in a growing number of jurisdictions to enact the reform.
Exploring the companies and themes that make up this emerging and exciting new sector
Compass Pathways 2.0: A New Rally In Psychedelic Stocks?
Compass Pathways lifted the whole sector in 2020. With CMPS again rising, is history about to repeat?
Psilocybin-assisted psychotherapy might help to reduce attachment anxiety
Scientists have begun to examine whether the psychedelic drug psilocybin, the active component of “magic” mushrooms, can help people who feel insecure in their attachments to others.
Italian Activists Turn In More Than Half A Million Signatures For Marijuana And Psilocybin Referendum
Italian activists on Thursday formally turned in about 630,000 signatures for a referendum to legalize the personal cultivation of marijuana and other psychoactive plants and fungi like psilocybin mushrooms.
Psychedelics Clinics Race Gaining Momentum
The rapidly expanding networks of psychedelics-based treatment clinics is a horse race where EVERYONE is a winner.
MINDCURE Announces Financial Results for the First Quarter of Fiscal 2022
MINDCURE announces its Q1 fiscal 2022 results, including initial release of its iSTRYM platform. Cash and equivalents of CAD$15.6 million as of August 31, 2021.
MindMed Expands its Drug Development Pipeline with Launch of R(-)-MDMA Program
MindMed announces a new R&D initiative focused on an MDMA derivative, and aimed at treating social anxiety.
Cybin Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using Kernel Flow Technology
Cybin receives IND authorization from the FDA to study ketamine's psychedelic effect on the cerebral cortex.
Levitee Labs Enters into Credit Facility For Up To $12 Million
Levitee Labs announces new credit facility for up to CAD$12 million to finance expansion of its clinics network.
The Psychedelics Revolution is EVERYWHERE
Psychedelic drugs are all over the news. Not just general news but also business media. Big news. Big Business.
Psychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up?
Cash-rich psychedelic stocks are cheap. They are also building value for investors -- at an accelerating rate.
Fourth Massachusetts City Approves Psychedelics Reform As Movement Grows
A fourth Massachusetts city has enacted a psychedelics policy change, with members of the Easthampton City Council voting on Wednesday in favor of a resolution urging the decriminalization of certain entheogenic substances and other drugs.